Eli Lilly
LLY
$10.50 (-0.94%)
1D
1W
3M
1Y
5Y
ALL
Eli Lilly and Company is a drug manufacturing company. The Company is engaged in the discovery, development, manufacturing, marketing, and sales of pharmaceutical products across the world. The Company's diabetes products include Baqsimi, Basaglar, Humalog, Humulin, Jardiance, Lyumjev, Trajenta and Trulicity. Its oncology products include Alimta, Cyramza, Erbitux, Retevmo, Tyvyt and Verzenio. The Company's immunology products consist of Olumiant and Taltz. Its neuroscience products include Cymbalta, Emgality, Reyvow and Zyprexa. Its other therapies consist of Bamlanivimab, etesevimab, Cialis and Forteo. The Company manufactures and distributes its products through facilities in the United States, including Puerto Rico, and about eight other countries. Its products are sold in approximately 120 countries. Its subsidiaries include Acanthas Pharma, Inc., Alnara Pharmaceuticals, Inc., ARMO Biosciences, Inc., and Avid Radiopharmaceuticals, Inc., among others.
Open
Prior close
Today's high
Today's low
52 Week high
52 Week low
Forbes • 12 hours ago • LLY
Ozempic Linked To Lower Risk Of Violence In New Study
Barrons • 1 day ago • LLY
Eli Lilly Takes Another Stab at the Market for Painkillers. This Attempt Might Work.
Schwab Network • 2 days ago • LLY
How LLY Overtook NVO in GLP-1 Space & Offering LLY Options Trade
The Motley Fool • 2 days ago • LLY
Should You Buy Eli Lilly Stock Now or Wait for a Dip?
The Motley Fool • 4 days ago • LLY
3 Reasons to Buy Eli Lilly Stock Like There's No Tomorrow
Charts and pricing are provided for informational purposes only. The current market data is delayed up to 15 minutes. The accuracy of any market data displayed is not guaranteed.